深圳康美生物科技股份有限公司

Founded in 2007, Kangmei Biotechnology Co., Ltd. is specialized in R&D, manufacturing, marketing & sales of bio-medical products in China. In March 2008, Beijing Kangmei Tianhong Biotechnology Co., Ltd. was established. In June 2009, Kangmei Biotechnology Co., Ltd. was rewarded as high-tech enterprise. In 2011, Kangmei Biotechnology Co., Ltd. acquired Wuhan Changli Biotechnology Co., Ltd. The latter was certified to ISO13485 and moved to Wuhan Optics Valley International Biomedical enterprise accelerator park. In 2013, Beijing Kangmei Tianhong Biotechnology Co., Ltd. certified to the ISO9001 and ISO13485 of TUV. The products have verified the CE certification, and obtained three new product registration certificates of Ureaplasma urealyticum, Neisseria gonorrhoeae and Chlamydia trachomatis. In 2018, Kangmei hosted the China Conference on Mass Spectrometry Database for Clinical Microbial Identification. Kangmei has our own R&D center lead by outstanding scientists and experts specialized in clinical medicine, immunology, molecular biology, microbiology, and medical testing, with various advanced experimental instruments and equipment. Focusing on the company’s development strategy, insisting on the combination of independent and collaborative R&D, focusing on disease diagnosis, prediction, and evaluation, with unique R&D advantages.